5640
ZW439, a novel CLDN18.2-targeting pan-RAS inhibitor antibody drug conjugate for the treatment of RAS mutated pancreatic cancerSam Lawn, Andrea Hernández Rojas, Vidhi Khanna, Jodi Wong, Ambroise Wu, Matthew Bonderud, Victoria Harman-McKenna, Taixiang Wang, Allysha Bissessur, Kaylee Wu, Manuel Lasalle, Vincent Fung, Chayne L. Piscitelli, Dunja Urosev, Luying Yang, Graham A. Garnett, Raffaele Colombo, Jamie R. Rich, Stuart D. Barnscher
读摘要原文 →